Skip Nav Destination
Article navigation
Meeting Abstracts|
September 2000
Room 224-226, 10/16/2000 9: 00 AM - 10: 30 AM (PD) The Ultra-Short Acting Nondepolarizing Relaxant GW280430A Undergoes Rapid Degradation by Chemical Mechanisms : A-1037
Depts. of Bioanalysis and Analytical Chemistry, Glaxo Wellcome Company, Research Triangle Park, NC, United States.
Anesthesiology September 2000, Vol. 93, A–1037.
Citation
M. McNulty, A. Brown, R. Johnson, T. Spitzer, J. Savarese; Room 224-226, 10/16/2000 9: 00 AM - 10: 30 AM (PD) The Ultra-Short Acting Nondepolarizing Relaxant GW280430A Undergoes Rapid Degradation by Chemical Mechanisms : A-1037. Anesthesiology 2000; 93:A–1037 doi: https://doi.org/10.1097/00000542-200009001-01037
Download citation file:
111
Views
0
Citations
Citing articles via
Most Viewed
Related Articles
Preclinical Pharmacology of GW280430A (AV430A) in the Rhesus Monkey and in the Cat: A Comparison with Mivacurium
Anesthesiology (April 2004)
Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-Cysteine
Anesthesiology (November 2018)
Clinical Pharmacology of GW280430A in Humans
Anesthesiology (April 2004)
Cardiopulmonary Effects of the Novel Neuromuscular Blocking Drug GW280430A (AV430A) in Dogs
Anesthesiology (April 2004)
